Newsroom News Archive Publications Contact Us for Experts
Media Contacts
Kim Guenther
(215) 662-6183

Related Links
Perelman School of Medicine
University of Pennsylvania Health System

Recommend Story
 
> Epigenetics Shapes Fate of Brain vs. Brawn Castes in Carpenter Ants
> Molecular Master Switch for Pancreatic Cancer Identified, Potential Predictor of Treatment Outcome
> Eat to Dream: Penn Study Shows Dietary Nutrients Associated with Certain Sleep Patterns
  All News Releases
 
    Media Resources
 
spacerNEWS RELEASE spacer
MAY 28 , 2008
  Penn Neurodegenerative Disease Researcher Receives Burroughs Wellcome Fund Career Award and AAN Foundation/ALS Association Clinician-Scientist Development Fellowship
   
   

PHILADELPHIA – Alice Chen-Plotkin, MD, NRSA Post-Doctorate Fellow at the University of Pennsylvania Center for Neurodegenerative Disease Research, has received a Career Award for Medical Scientists from the Burroughs Wellcome Fund. Recently, she also received the 2008 Clinician-Scientist Development Fellowship award from the American Academy of Neurology (AAN) Foundation and The ALS Association.

Alice Chen-Plotkin

Alice Chen-Plotikin, MD

Dr. Chen-Plotkin, Center for Neurodegenerative Disease Research directors Virginia M.-Y. Lee, PhD, MBA and John Q. Trojanowski, MD, PhD and colleagues are homing in on a protein called TDP-43, which is seen in people with amyotrophic lateral sclerosis (ALS) and a type of dementia called frontotemporal dementia.

“The BWF and AAN awards will allow us to deepen our understanding of TDP-43, which we’ve already shown to be associated with neurodegenerative diseases including ALS and frontotemporal dementia,” says Chen-Plotkin. By better understanding TDP-43’s role in regulating gene expression and defining patterns of abnormal gene expression in people with ALS and frontotemporal dementia, researchers hope to trace causes and ultimately develop effective therapies to treat these devastating neurodegenerative diseases.

The BWF Career Award for Medical Scientists (CAMS) program provides $700,000 over five years to bridge advanced postdoctoral/fellowship training and the early years of faculty service. The award, which was given to 16 researchers out of 124 applicants, supports the last years of a mentored position as well as the beginning years of an independent position. Dr. Chen-Plotkin’s husband, Josh Plotkin, PhD, is a previous recipient of a separate award from BWF, the Career Award at the Scientific Interface (CASI), and is an Assistant Professor of Biology and Computer and Information Science in the University of Pennsylvania School of Arts and Sciences.

The AAN Foundation/ALS Association Clinician Scientist Development Fellowship is part of The Association’s TREAT ALS™ program. The two-year, $160,000 fellowship was formally presented during the American Academy of Neurology's 60th Annual Meeting in Chicago, held April 12–19, 2008. Dr. Chen-Plotkin’s Department of Neurology colleague, William Hu, MD, PhD, received a 2008 Clinical Research Training Fellowship to research whether the amount of TDP-43 in cerebral spinal fluid may correlate to and possible predict specific degenerative conditions.

Chen-Plotkin received her MD from Harvard University in 2003, a master's degree in biological sciences from Oxford University, where she was a Rhodes scholar, and graduated magna cum laude from Harvard University with B.A. in English. She completed her neurology residency at Brigham and Women's Hospital and Massachusetts General Hospital before coming to Penn in late 2007. In addition to her research, she continues to see patients at the Penn Parkinson's Disease and Movement Disorders Center.

For more information:

###

PENN Medicine is a $3.5 billion enterprise dedicated to the related missions of medical education, biomedical research, and excellence in patient care. PENN Medicine consists of the University of Pennsylvania School of Medicine (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System.

Penn's School of Medicine is currently ranked #4 in the nation in U.S.News & World Report's survey of top research-oriented medical schools; and, according to most recent data from the National Institutes of Health, received over $379 million in NIH research funds in the 2006 fiscal year. Supporting 1,400 fulltime faculty and 700 students, the School of Medicine is recognized worldwide for its superior education and training of the next generation of physician-scientists and leaders of academic medicine.

The University of Pennsylvania Health System includes three hospitals — its flagship hospital, the Hospital of the University of Pennsylvania, rated one of the nation’s “Honor Roll” hospitals by U.S.News & World Report; Pennsylvania Hospital, the nation's first hospital; and Penn Presbyterian Medical Center — a faculty practice plan; a primary-care provider network; two multispecialty satellite facilities; and home care and hospice.

 



About Penn Medicine   Contact Us   Site Map   Privacy Statement   Legal Disclaimer   Terms of Use

Penn Medicine, Philadelphia, PA 800-789-PENN © 2013, The Trustees of the University of Pennsylvania